{"CVE Code": "CVE-2017-18228", "Description": "Remedy Mid Tier in BMC Remedy AR System 9.1 allows XSS via the ATTKey parameter in an arsys/servlet/AttachServlet request.", "NVD Link": "https://nvd.nist.gov/vuln/detail/CVE-2017-18228", "Vulnerability Categories": "Cross site scripting (XSS)", "Affected Products": "\nBMC\u00bbRemedy Action Request SystemVersions  up to, including, (<=) 9.1cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:*Matching versions", "EPSS Score": "0.05% Probability of exploitation activity in the next 30 days\n~ 21 % Percentile, the proportion of vulnerabilities that are scored at or less", "EPSS History": "\n #  Date  Old EPSS Score  New EPSS Score  Delta (New - Old) \n 1  2024-04-25  0.05%  0.05%  +0.00 \n 2  2024-02-09  0.05%  0.05%  0.00 \n 3  2023-03-07  0.89%  0.05%  -0.83 ", "CVSS Scores": "3.5", "CWE": [{"CWE_ID": "CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')", "CWE_link": "/cwe-details/79/Improper-Neutralization-of-Input-During-Web-Page-Generation-.html"}], "Reference": [{"ref_link": "https://communities.bmc.com/thread/164169", "ref_desc": "XSS vulnerability with BMC Remedy Web-Mid Tier ... | BMC CommunitiesVendor Advisory", "ref_cve_link": "N/A"}]}